Expertise in
3
conditions

Dr. Ravneet Thind

Hematology
St Claire Medical Center Inc
245 Flemingsburg Rd, 
Morehead, KY 
Offers Telehealth
Expertise in
3
conditions
St Claire Medical Center Inc
245 Flemingsburg Rd, 
Morehead, KY 

Overview

Ravneet Thind is a Hematologist practicing medicine in Morehead, Kentucky.

Dr. Thind is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Small Lymphocytic Lymphoma (SLL), Gastroesophageal Junction Cancer, and Leukocytosis.

She is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 4 clinical trials.

Specialties

Hematology

Licenses

Internal Medicine in KY

Hospital Affiliations

St Claire Regional Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

St Claire Medical Center Inc
245 Flemingsburg Rd, Morehead, KY 40351
Other Locations
Kentucky Children's Hospital
800 Rose St, Lexington, KY 40536

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: July 17, 2025
Intervention Type: Other, Drug
Study Drug: Naloxegol
Study Phase: Phase 2
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Drug
Study Drug: Rucaparib
Study Phase: Phase 2
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug, Biological
Study Drugs: Docetaxel, Gemcitabine, Gemcitabine Hydrochloride, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Ramucirumab
Study Phase: Phase 2
View 3 Less Clinical Trials

6 Total Publications

Infectious morbidity associated with early amniotomy during labor induction.
Infectious morbidity associated with early amniotomy during labor induction.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: August 31, 2024
Similar Doctors
Expertise in
46
conditions
Dr. Firas Badin
Hematology | Oncology
Expertise in
46
conditions
Dr. Firas Badin
Hematology | Oncology
Referral may be required

Baptist Health Medical Group-Palliative Medicine

1700 Nicholasville Rd Ste 1100, 
Lexington, KY 
 (60.6 miles away)
859-276-0414
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Firas Badin is a Hematologist and an Oncologist practicing medicine in Lexington, Kentucky. Dr. Badin is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Badin is currently accepting new patients.

Expertise in
29
conditions
Dr. Chad J. Tarabolous
Hematology | Oncology
Expertise in
29
conditions
Dr. Chad J. Tarabolous
Hematology | Oncology
Referral may be required

Bellefonte Physician Services Inc.

100 Bellefonte Dr, 
Grayson, KY 
 (28.6 miles away)
606-329-9335
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chad Tarabolous is a Hematologist and an Oncologist practicing medicine in Grayson, Kentucky. Dr. Tarabolous is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Lung Cancer. Dr. Tarabolous is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

Saint Joseph Health - Cancer Care Center - Mount Sterling, KY

227 Falcon Dr Ste 103, 
Mount Sterling, KY 
 (28.7 miles away)
859-215-7402
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Scott Pierce is a Hematologist practicing medicine in Mount Sterling, Kentucky. Dr. Pierce is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Pierce is currently accepting new patients.

Frequently Asked Questions about Dr. Ravneet Thind

How do I make an appointment with Dr. Ravneet Thind?

You can book an appointment with Dr. Ravneet Thind by calling their office at 606-780-5500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ravneet Thind a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ravneet Thind is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ravneet Thind specialize in?

While Dr. Ravneet Thind is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Small Lymphocytic Lymphoma (SLL), and Gastroesophageal Junction Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Ravneet Thind participate in research or clinical trials?

Yes. Dr. Ravneet Thind has published 6 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Ravneet Thind's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ravneet Thind accept my insurance?

Dr. Ravneet Thind accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 606-780-5500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thind's expertise for a condition
ConditionClose
      View All 48 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile